Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Vribose M Voglibose and Metformin Tablets
Vribose M, provided by Lexaro Healthcare, combines voglibose and metformin in each tablet to offer effective management of type 2 diabetes. This formulation is designed to improve glycemic control by addressing different aspects of blood sugar regulation.
Uses of Vribose M Voglibose and Metformin Tablets
Vribose M is primarily prescribed for:
Managing blood sugar levels in individuals with type 2 diabetes mellitus.
Enhancing glycemic control by combining the effects of Voglibose and Metformin.
Reducing postprandial (after meal) blood glucose spikes.
Improving overall blood sugar management and reducing HbA1c levels.
Benefits of Vribose M Voglibose and Metformin Tablets
Provides dual action with Voglibose and Metformin for effective blood sugar control.
Reduces postprandial blood glucose spikes, helping to stabilize glucose levels.
Improves overall glycemic control and reduces HbA1c levels.
Helps in managing type 2 diabetes more effectively than monotherapy.
Convenient tablet formulation for easy administration.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Vribose M Voglibose and Metformin Tablets
Voglibose is an alpha-glucosidase inhibitor that works by delaying the absorption of carbohydrates from the intestines. This action reduces postprandial blood glucose spikes by slowing down the breakdown of carbohydrates into glucose, thereby helping to manage blood sugar levels more effectively.
Metformin is a biguanide that improves insulin sensitivity and reduces hepatic glucose production. It enhances the uptake and utilization of glucose by peripheral tissues and decreases the liver's glucose output, contributing to better overall blood glucose control.
The combination of Voglibose and Metformin in Vribose M offers a comprehensive approach to managing type 2 diabetes by addressing both postprandial glucose spikes and overall insulin sensitivity.